Shattuck Labs (STTK) Accumulated Expenses (2019 - 2026)
Shattuck Labs (STTK) reported Accumulated Expenses of $3.0 million for Q1 2026, down 48.18% year-over-year from $5.8 million in Q1 2025, and down 39.49% quarter-over-quarter from $5.0 million in Q4 2025.
Shattuck Labs (STTK) Accumulated Expenses (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Accumulated Expenses data on file, last reported at $3.0 million in Q1 2026.
- Accumulated Expenses for Q1 2026 came in at $3.0 million, down 48.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 million (down 48.18% YoY), and the FY2025 annual result was $5.0 million, down 23.81% from the prior year.
- Accumulated Expenses fell to $3.0 million in Q1 2026 per STTK's latest filing, from $5.0 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $18.6 million in Q2 2022 and troughed at $3.0 million in Q1 2026.
- A 5-year average of $9.5 million and a median of $9.5 million in 2024 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2025: Accumulated Expenses soared 1521.55% in 2022, then slumped 55.94% in 2025.
- A 5-year view of Accumulated Expenses shows it stood at $17.8 million in 2022, then sank by 44.56% to $9.9 million in 2023, then tumbled by 34.14% to $6.5 million in 2024, then fell by 23.81% to $5.0 million in 2025, then sank by 39.49% to $3.0 million in 2026.
- Business Quant data shows STTK's Accumulated Expenses at $3.0 million in Q1 2026, $5.0 million in Q4 2025, and $4.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 4.95 Mn |
| Sep 30, 2025 | 4.17 Mn |
| Jun 30, 2025 | 4.86 Mn |
| Mar 31, 2025 | 5.78 Mn |
| Dec 31, 2024 | 6.50 Mn |
| Sep 30, 2024 | 9.47 Mn |
| Jun 30, 2024 | 6.50 Mn |
| Mar 31, 2024 | 7.57 Mn |
| Dec 31, 2023 | 9.87 Mn |
| Sep 30, 2023 | 12.04 Mn |
| Jun 30, 2023 | 9.52 Mn |
| Mar 31, 2023 | 10.88 Mn |
| Dec 31, 2022 | 17.80 Mn |
| Sep 30, 2022 | 16.10 Mn |
| Jun 30, 2022 | 18.57 Mn |
| Mar 31, 2022 | 14.22 Mn |
| Dec 31, 2021 | 14.57 Mn |
| Sep 30, 2021 | 13.78 Mn |
| Jun 30, 2021 | 1.80 Mn |